by admin | Mar 14, 2022 | Insights
The United Kingdom are urging Cabinet ministers to reclassify psilocybin so that researchers can explore its potential as a medicine. The same demand is being made by people suffering from cluster headaches, amid evidence that psilocybin can help reduce both the...
by admin | Mar 9, 2022 | Insights
Next Avenue with a comprehensive primer on psychedelic-assisted therapies. #psychedelicscience #psilocybin #psychedelictherapy #psychedelicmedicine #changeyourmind Link to post Link to...
by admin | Mar 9, 2022 | Insights
“Just a few years ago, the promise of psychedelics being embraced by mainstream culture and lawmakers in the United States still seemed like a hopeful hallucination rather than a concrete reality. But now, two months into 2022, development after development...
by admin | Mar 9, 2022 | Insights
A new series of studies suggest that taking a #psychedelic trip could provide a neurological reset to those struggling with addiction, making it easier to ditch harmful substances like alcohol and cigarettes. While this research is still in its early stages, we will...
by admin | Mar 2, 2022 | Insights
According to a new study, the active ingredient in magic mushrooms may be able to relieve symptoms in adults suffering from major depressive disorder for up to a year. “Our findings add to evidence that, under carefully controlled conditions, this is a promising...
by admin | Mar 2, 2022 | Insights
In the early 1960s, the Harvard Psilocybin Project made national headlines for its research methods and controversial leader. Sixty years after the departure of Timothy Leary, Harvard University (along with many other well-respected academic institutions around the...
Recent Comments